These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 20212084)
21. SGK1 activation exacerbates diet-induced obesity, metabolic syndrome and hypertension. Sierra-Ramos C; Velazquez-Garcia S; Vastola-Mascolo A; Hernández G; Faresse N; Alvarez de la Rosa D J Endocrinol; 2020 Jan; 244(1):149-162. PubMed ID: 31600722 [TBL] [Abstract][Full Text] [Related]
22. Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: The muffin study. Miller M; Sorkin JD; Mastella L; Sutherland A; Rhyne J; Donnelly P; Simpson K; Goldberg AP J Clin Lipidol; 2016; 10(4):996-1003. PubMed ID: 27578132 [TBL] [Abstract][Full Text] [Related]
23. How to transform a metabolic syndrome score into an insulin sensitivity value? Hermans MP; Bouenizabila E; Ahn SA; Rousseau MF Diabetes Metab Res Rev; 2016 Jan; 32(1):87-94. PubMed ID: 26111860 [TBL] [Abstract][Full Text] [Related]
24. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102 [TBL] [Abstract][Full Text] [Related]
25. Genetics of metabolic syndrome: potential clues from wild-derived inbred mouse strains. Karunakaran S; Clee SM Physiol Genomics; 2018 Jan; 50(1):35-51. PubMed ID: 29127221 [TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study. Tiehuis AM; van der Graaf Y; Mali WP; Vincken K; Muller M; Geerlings MI; Diabetes Care; 2014 Sep; 37(9):2515-21. PubMed ID: 24947788 [TBL] [Abstract][Full Text] [Related]
27. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project. Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572 [TBL] [Abstract][Full Text] [Related]
28. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896 [TBL] [Abstract][Full Text] [Related]
29. Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. Johnson LA; Zuloaga KL; Kugelman TL; Mader KS; Morré JT; Zuloaga DG; Weber S; Marzulla T; Mulford A; Button D; Lindner JR; Alkayed NJ; Stevens JF; Raber J EBioMedicine; 2016 Jan; 3():26-42. PubMed ID: 26870815 [TBL] [Abstract][Full Text] [Related]
30. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896 [TBL] [Abstract][Full Text] [Related]
31. Mice lacking Gallo-Ebert C; Francisco J; Liu HY; Draper R; Modi K; Hayward MD; Jones BK; Buiakova O; McDonough V; Nickels JT J Biol Chem; 2018 Apr; 293(16):5956-5974. PubMed ID: 29491146 [TBL] [Abstract][Full Text] [Related]
32. Alteration of Liver Peroxisomal and Mitochondrial Functionality in the NZO Mouse Model of Metabolic Syndrome. Knebel B; Göddeke S; Hartwig S; Hörbelt T; Fahlbusch P; Al-Hasani H; Jacob S; Koellmer C; Nitzgen U; Schiller M; Lehr S; Kotzka J Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 29068532 [TBL] [Abstract][Full Text] [Related]
33. Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease. Nakamura A; Sato K; Kanazawa M; Kondo M; Endo H; Takahashi T; Nozaki E Heart Vessels; 2019 Jun; 34(6):916-925. PubMed ID: 30519809 [TBL] [Abstract][Full Text] [Related]
34. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults. Supriya R; Tam BT; Yu AP; Lee PH; Lai CW; Cheng KK; Yau SY; Chan LW; Yung BY; Sheridan S; Siu PM PLoS One; 2018; 13(8):e0201585. PubMed ID: 30114249 [TBL] [Abstract][Full Text] [Related]
35. β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. Hudish LI; Reusch JE; Sussel L J Clin Invest; 2019 Oct; 129(10):4001-4008. PubMed ID: 31424428 [TBL] [Abstract][Full Text] [Related]
36. Association of Rana S; Sultana A; Bhatti AA J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502573 [TBL] [Abstract][Full Text] [Related]
40. Poor Sleep Quality is Associated with Insulin Resistance in Postmenopausal Women With and Without Metabolic Syndrome. Kline CE; Hall MH; Buysse DJ; Earnest CP; Church TS Metab Syndr Relat Disord; 2018 May; 16(4):183-189. PubMed ID: 29649378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]